Trial Profile
Phase II Trial of Pirfenidone in Children, Adolescents, and Young Adults With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Apr 2018
Price :
$35
*
At a glance
- Drugs Pirfenidone (Primary)
- Indications Neurofibromatosis 1; Plexiform neurofibroma
- Focus Adverse reactions; Therapeutic Use
- 30 Nov 2015 New trial record